| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7511590 | International Journal of Drug Policy | 2018 | 10 Pages |
Abstract
Residual gaps in HCV knowledge and continuing negative perceptions related to interferon-based therapy highlight the need to scale-up educational initiatives. Readiness for HCV treatment was particularly low among HIV/HCV co-infected and older PWID, emphasizing the importance of tailored treatment strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Eshan U. Patel, Sunil S. Solomon, Allison M. Mcfall, Aylur K. Srikrishnan, Amrose Pradeep, Paneerselvam Nandagopal, Oliver Laeyendecker, Aaron A.R. Tobian, David L. Thomas, Mark S. Sulkowski, M. Suresh Kumar, Shruti H. Mehta,